These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15062137)
1. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137 [TBL] [Abstract][Full Text] [Related]
2. Long-term rectal function after permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Gutman S; Lief J Cancer J; 2007; 13(2):95-104. PubMed ID: 17476137 [TBL] [Abstract][Full Text] [Related]
3. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy. Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149 [TBL] [Abstract][Full Text] [Related]
4. Rectal function following permanent prostate brachytherapy. Merrick GS; Butler WM W V Med J; 2004; 100(1):18-20. PubMed ID: 15119492 [TBL] [Abstract][Full Text] [Related]
5. Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer. Sherertz T; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W; True L Brachytherapy; 2004; 3(3):130-5. PubMed ID: 15533804 [TBL] [Abstract][Full Text] [Related]
6. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry. Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159 [TBL] [Abstract][Full Text] [Related]
7. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy. Niehaus A; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):136-43. PubMed ID: 16198062 [TBL] [Abstract][Full Text] [Related]
8. Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer. Orio PF; Merrick GS; Galbreath RW; Butler WM; Lief J; Wallner KE Brachytherapy; 2012; 11(5):341-7. PubMed ID: 22561216 [TBL] [Abstract][Full Text] [Related]
9. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Murray B; Allen Z; Lief JH; Galbreath RW Brachytherapy; 2004; 3(1):22-9. PubMed ID: 15110310 [TBL] [Abstract][Full Text] [Related]
10. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722 [TBL] [Abstract][Full Text] [Related]
16. Factors predicting for urinary incontinence after prostate brachytherapy. McElveen TL; Waterman FM; Kim H; Dicker AP Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1395-404. PubMed ID: 15275725 [TBL] [Abstract][Full Text] [Related]
17. Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors. Shah JN; Ennis RD Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):817-24. PubMed ID: 16297567 [TBL] [Abstract][Full Text] [Related]
18. Permanent prostate brachytherapy in prostate glands <20 cm(3). Mayadev J; Merrick GS; Reed JR; Butler WM; Galbreath RW; Allen ZA; Wallner KE Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1450-5. PubMed ID: 20338476 [TBL] [Abstract][Full Text] [Related]
19. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008 [TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]